Propofol and methohexital have no significant effect on mucus secretion or clearance in the anesthetized dog

G S Padda1, C Kishioka, B K Rubin

  • 1St. Louis University Department of Anesthesiology, St. Louis, MO, USA.

Abstract

Insights

Neither methohexital nor propofol anesthesia significantly altered airway mucus properties or transport in dogs. Atropine premedication reduced secretion volume and increased potential difference, but did not affect mucus clearance with either anesthetic.

Area of Science:

  • Anesthesiology
  • Pulmonary Physiology
  • Pharmacology

Background:

  • Anecdotal evidence suggests propofol may increase mucus secretion.
  • Understanding anesthetic effects on airway mucus is crucial for patient care.
  • Airway mucus plays a vital role in respiratory health and defense.

Purpose of the Study:

  • To investigate the impact of methohexital and propofol anesthesia on canine airway mucus.
  • To evaluate the physical and transport characteristics of mucus under different anesthetic conditions.

Main Methods:

  • A randomized, controlled, crossover laboratory study was conducted on four healthy beagle dogs.
  • Dogs received either propofol or methohexital anesthesia, with or without atropine premedication.
  • Measurements included mucus secretion volume, viscoelasticity, transport velocity, and epithelial potential difference.

Main Results:

  • Neither methohexital nor propofol significantly affected mucus physical or transport properties.
  • Atropine premedication led to significantly lower secretion volume and higher epithelial potential difference.
  • No significant differences in mucus transport velocity, viscoelasticity, or mucociliary transportability were observed with either anesthetic or atropine.

Conclusions:

  • Methohexital and propofol anesthesia do not appear to significantly impact mucus secretion or clearance in healthy dogs.
  • Atropine's effects on mucus secretion and potential difference were observed, but did not alter overall mucus transport.
  • These findings suggest that neither anesthetic agent poses a significant risk for mucus-related complications in this model.

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...